About MED Molecular
Integrating diagnostic technology with patient care is critical. Too often clinics and physicians are unaware of the latest tests and testing protocols. This is due primarily to a lack of adequate support and education from what they believe to be their only options for laboratory testing. That paradigm has changed. MED Molecular empowers physicians by providing turnkey solutions through its network of laboratory partnerships. MED Molecular streamlines all aspects of the clinical diagnostic process without any additional burden on the physician or their staffs. MED Molecular provides unlimited testing access and expertise through a single point of contact.
Clinical Testing
Molecular Diagnostics
​
Molecular diagnostics is a broad term describing a class of diagnostic tests that assess a person's health literally at a molecular level, detecting and measuring specific genetic sequences in deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) or the proteins they express.
Infectious Disease
By using a molecular syndromic approach and a broad test menu, one easy diagnostic test can better detect and identify the infectious agent. Infectious disease testing increases the probability of identifying a pathogen in patients with symptoms of an infectious disease and increases the capability of detection of co-infections.
Women's Health
This platform was designed to serve the OB/GYN practitioner. The panels include all relevant tests in women's health, including conventional Pap tests to molecular diagnostic testing for infectious diseases.
Pharmacogenomics
This is the study of how genetic differences affect an individual’s response to medication. The technology used by our laboratories can easily test for gene variability, providing you with the necessary knowledge to choose the safest and most effective medications for your patients.
Toxicology
​
Toxicology screens are used to identify substances affecting a patient and to guide the clinician to predict future toxic effects, to confirm the differential diagnosis or to guide therapy. Ensure medication effectiveness while satisfying regulatory requirements with MED Molecular toxicology services.
Chemistry & Hematology
We offer a full array of laboratory services with both accuracy and speed, which are vital for this type of data, upon which so many treatment decisions are based.
Prosigna PAM50
This is a genetic signature test capable of identifying the individual risk of late recurrence in postmenopausal women diagnosed with breast cancer at an early stage. The gene expression profile of a patient's tumor is compared with each of the four PAM50 prototypical molecular profiles to determine the degree of similarity.
​
Nutrigenomics
Also commonly referred to as "the DNA diet", this panel develops targeted solutions for metabolism, weight control and skin therapy. Informative and cost-effective, Nutrigenomics provides critical information for tailoring the most accurate diet and wellness plans.
Hereditary Cancer
MED Molecular has partnered with labs offering the most advanced testing platforms for hereditary testing on the market today. Hereditary panels analyze the most frequent syndromes that present predispositions to cancer. There are many options today to make informed choices about the future.
ONE PARTNERSHIP UNLIMITED TESTING
